KR20010087421A - 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 - Google Patents

4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 Download PDF

Info

Publication number
KR20010087421A
KR20010087421A KR1020017007552A KR20017007552A KR20010087421A KR 20010087421 A KR20010087421 A KR 20010087421A KR 1020017007552 A KR1020017007552 A KR 1020017007552A KR 20017007552 A KR20017007552 A KR 20017007552A KR 20010087421 A KR20010087421 A KR 20010087421A
Authority
KR
South Korea
Prior art keywords
dihydro
methylene
methoxy
indol
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017007552A
Other languages
English (en)
Korean (ko)
Inventor
룩킨-춘
마하니파이지이.
미슈케스티븐그레고리
Original Assignee
프리돌린 클라우스너, 롤란드 비. 보레르
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 비. 보레르, 에프. 호프만-라 로슈 아게 filed Critical 프리돌린 클라우스너, 롤란드 비. 보레르
Publication of KR20010087421A publication Critical patent/KR20010087421A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020017007552A 1998-12-17 1999-12-07 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 Ceased KR20010087421A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11258998P 1998-12-17 1998-12-17
US60/112,589 1998-12-17
US14148299P 1999-06-29 1999-06-29
US60/141,482 1999-06-29
PCT/EP1999/009578 WO2000035906A2 (en) 1998-12-17 1999-12-07 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles

Publications (1)

Publication Number Publication Date
KR20010087421A true KR20010087421A (ko) 2001-09-15

Family

ID=26810125

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017007552A Ceased KR20010087421A (ko) 1998-12-17 1999-12-07 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌

Country Status (14)

Country Link
EP (1) EP1149092B1 (https=)
JP (1) JP2002532490A (https=)
KR (1) KR20010087421A (https=)
CN (1) CN1147486C (https=)
AT (1) ATE253062T1 (https=)
AU (1) AU771599B2 (https=)
BR (1) BR9916272A (https=)
CA (1) CA2354510A1 (https=)
DE (1) DE69912479T2 (https=)
DK (1) DK1149092T3 (https=)
ES (1) ES2209527T3 (https=)
PT (1) PT1149092E (https=)
TR (1) TR200101747T2 (https=)
WO (1) WO2000035906A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
JP2003535847A (ja) 2000-06-02 2003-12-02 スージェン・インコーポレーテッド 蛋白質キナーゼ/ホスファターゼ阻害剤としてのインドリノン誘導体
WO2002002551A1 (en) * 2000-06-30 2002-01-10 Sugen, Inc. 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
CN1300116C (zh) 2001-04-16 2007-02-14 卫材株式会社 1h-吲唑化合物
US7018999B2 (en) 2001-05-16 2006-03-28 Cephalon, Inc. Methods for the treatment and prevention of pain
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
JP4414219B2 (ja) 2001-07-23 2010-02-10 メルク セローノ ソシエテ アノニム C−jun−n−末端キナーゼ(jnk)インヒビターとしてのアリールスルホンアミド誘導体
EP1434585A1 (en) * 2001-10-12 2004-07-07 Warner-Lambert Company LLC Alkyne matrix metalloproteinase inhibitors
US6962922B2 (en) 2001-10-12 2005-11-08 Warner-Lambert Company Llc Alkynylated quinazoline compounds
ATE465153T1 (de) 2002-02-28 2010-05-15 Eisai R&D Man Co Ltd Neue indazolverbindungen mit kondensiertem ring
US6894057B2 (en) 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
US6747147B2 (en) 2002-03-08 2004-06-08 Warner-Lambert Company Oxo-azabicyclic compounds
US7429609B2 (en) 2002-05-31 2008-09-30 Eisai R & D Management Co., Ltd. Pyrazole compound and medicinal composition containing the same
WO2003106455A1 (en) 2002-06-14 2003-12-24 Applied Research Systems Ars Holding N.V. Azole methylidene cyanide derivatives and their use as protein kinase modulators
RU2006117635A (ru) 2003-10-24 2007-12-10 Шеринг Акциенгезельшафт (De) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
US7803824B2 (en) 2004-10-29 2010-09-28 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US20060094753A1 (en) 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
WO2006090698A1 (ja) * 2005-02-22 2006-08-31 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
US7968572B2 (en) 2005-10-03 2011-06-28 Ono Pharmaceuticals Co., Ltd. Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
FR2962729B1 (fr) 2010-07-13 2012-09-21 Arkema France Molecules porteuses de groupes associatifs
FR2962733B1 (fr) 2010-07-13 2012-08-17 Michelin Soc Tech Polymere greffe par des molecules associatives azotees.
US20140205537A1 (en) * 2011-06-24 2014-07-24 Zenobia Therapeutics, Inc. Lrrk2 inhibitors
CN214057141U (zh) 2019-11-27 2021-08-27 财团法人工业技术研究院 发电感测传输装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
DE69734521T9 (de) * 1996-08-23 2006-12-07 Sugen, Inc., South San Francisco Kombinatorische indolinonbibliotheken und verwandte produkte und verfahren zur behandlung von erkrankungen
JP2002511852A (ja) * 1997-05-07 2002-04-16 スージェン・インコーポレーテッド 蛋白質キナーゼ活性の調節剤としての2−インドリノン誘導体

Also Published As

Publication number Publication date
EP1149092B1 (en) 2003-10-29
WO2000035906A2 (en) 2000-06-22
WO2000035906A3 (en) 2000-11-09
CN1147486C (zh) 2004-04-28
PT1149092E (pt) 2004-03-31
ATE253062T1 (de) 2003-11-15
ES2209527T3 (es) 2004-06-16
AU771599B2 (en) 2004-03-25
BR9916272A (pt) 2001-09-04
CN1331689A (zh) 2002-01-16
TR200101747T2 (tr) 2001-11-21
JP2002532490A (ja) 2002-10-02
AU1507600A (en) 2000-07-03
EP1149092A2 (en) 2001-10-31
DE69912479D1 (de) 2003-12-04
DK1149092T3 (da) 2004-02-23
DE69912479T2 (de) 2004-07-22
CA2354510A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
EP1149092B1 (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
US6307056B1 (en) 4-aryloxindoles
KR100738165B1 (ko) 헤테로방향족 카르복사미드 유도체 및 ikk-2 효소억제제로서의 용도
KR100481757B1 (ko) Cdk2 억제제인 피라졸로벤조디아제핀
US5874427A (en) Substituted heteroaromatic 5-HT1F agonists
PL180027B1 (pl) Nowe zwiazki, skondensowane pirolokarboksyanilidy, bedace nowa klasa ligandów receptora mózgowego GABA PL PL PL PL PL PL PL PL
US6221867B1 (en) 4,5-pyrazinoxindoles
US5792766A (en) Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
KR20050098248A (ko) 효소 ikk-2의 저해제로서의 티오펜 카르복사미드
EP0126401A1 (de) Neue Indolverbindungen
US6313310B1 (en) 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
AU777702B2 (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
EP1501805A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
MXPA01006049A (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
KR100519831B1 (ko) 티에노피롤리디논
ZA200104281B (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles.
MXPA01006141A (en) 4-aryloxindoles as inhibitors of jnk protein kinases
ZA200104320B (en) 4-Aryloxindoles as inhibitors of JNK protein kinases.
KR20010039263A (ko) 간 섬유화 억제작용을 나타내는 벤조[3,4-d]1,3-디옥솔란 유도체

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010615

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20041206

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060418

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060626

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060418

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I